bpc 157 and tb 500 nasal spray BPC157/TB500 TB-500 Nasal Spray | Research

Why Choose the 250 ml Size

The evidence is promising, but it is preclinical

Favorable Safety Profile: Unlike full growth hormone therapy, AOD-9604 does not stimulate IGF-1 production or affect glucose metabolism

As an orally administered pentadecapeptide, the swallowed capsule is studied for its notable stability in gastric conditions, making it a candidate for investigating gut-associated cytoprotective mechanisms

Yes, many people with MS are able to have children, although they may need to work closely with their healthcare providers to manage their symptoms and treatment during pregnancy.

A 2025 preliminary safety study administered intravenous BPC-157 to 2 participants at escalating doses with no adverse effects reported, but the extremely limited sample size prevents meaningful conclusions